TrialNature medicine2025

Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial.

Farid H Mahmud et al.PubMed ↗Publisher ↗

No numbers read from the abstract.